Related Experiment Video
Updated: May 8, 2026

09:50
Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019
Paneth cells in gut GVHD: a Panglossian perspective
1Dana-Farber Cancer Institute.
Blood
|August 24, 2013
Summary
Paneth cell loss may significantly impact gastrointestinal acute graft-versus-host disease (GI GVHD) outcomes. This study explores the clinical relevance of Paneth cell depletion in managing GI GVHD.
Area of Science:
- Gastroenterology
- Hematology
- Immunology
Background:
- Gastrointestinal (GI) acute graft-versus-host disease (GVHD) is a serious complication following allogeneic stem cell transplantation.
- Paneth cells, crucial for intestinal immunity and barrier function, are implicated in GVHD pathogenesis.
- Understanding Paneth cell dynamics is vital for improving GI GVHD management.
Purpose of the Study:
- To analyze the clinical significance of Paneth cell loss in patients with GI acute GVHD.
- To investigate the correlation between Paneth cell depletion and clinical outcomes in GI GVHD.
Main Methods:
- Retrospective analysis of patient data undergoing allogeneic stem cell transplantation.
- Histopathological assessment of intestinal biopsies for Paneth cell counts.
- Correlation of Paneth cell numbers with clinical parameters of acute GVHD.
Main Results:
- Significant Paneth cell loss was observed in patients experiencing GI acute GVHD.
- Reduced Paneth cell counts were associated with increased GVHD severity and poorer clinical outcomes.
- Paneth cell depletion may serve as a predictive biomarker for GI GVHD.
Conclusions:
- Paneth cell loss is a clinically relevant finding in GI acute GVHD.
- Targeting or preserving Paneth cells could represent a novel therapeutic strategy for GI GVHD.
- Further research is warranted to elucidate the precise mechanisms and therapeutic potential.
Related Concept Videos
Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

